Pharma group leader says MPs who vote for reconciliation bill ‘will not get free pass’

“Regardless of the outcome of the coming weeks, this fight is not over,” Uble said in an interview. “Few associations have all the modern political advocacy tools at their disposal the way PhRMA does.”

Thursday’s letter largely echoes arguments the industry has made throughout the process, with executives from companies including Pfizer and Merck saying the legislation would lead to fewer treatments and cures — especially for serious diseases like cancer and Alzheimer’s disease, which can be difficult and expensive. development.

Ubl said one of PhRMA’s member companies has 15 drugs in the pipeline that would be withdrawn if the bill becomes law.

“This is a very productive vote. Members who support this bill will not get a free pass. We will do everything to hold them accountable,” he said.

It’s unclear when Senate Majority Leader Chuck Schumer will introduce the $740 billion reconciliation package, and senators hope to have to sit through the weekend as they move to resolve any delays and pass it as quickly as possible.

The stakes are high for the drug industry: Allowing Medicare to negotiate the cost of high-priced drugs is expected to save the federal government more than $100 billion. The move would “put the US system on a course of government control that will set our country back,” the letter to Congress said Thursday.

PhRMA has spent millions of dollars lobbying Democrats for drug price reform measures over the past two years, and millions more on television and digital ads to try to sway public opinion. In the first six months of 2022, the group spent more than $14.4 million in total lobbying, according to disclosure materials.

Ubl declined to say more about what kinds of legal arguments would be on the table — “fearing that arm-twisting would eliminate future options” — or what changes might come from future regulations or legislation.

“In my experience, when a bill like this is passed on a hyperpartisan basis with little margins and loopholes, it rarely sticks,” he said, pointing to all the changes that have been made to the Affordable Care Act since then. passage. “We expect there will be opportunities in the future to further reduce the harm of this legislation.”

Pharma group leader says MPs who vote for reconciliation bill ‘will not get free pass’

Source link Pharma group leader says MPs who vote for reconciliation bill ‘will not get free pass’

Exit mobile version